LARTRUVO (Eli Lilly and Company)
Welcome to the PulseAid listing for the LARTRUVO drug offered from Eli Lilly and Company. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Eli Lilly and Company |
NON-PROPRIETARY NAME: | olaratumab |
SUBSTANCE NAME: | OLARATUMAB |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2016-10-19 |
END MARKETING DATE: | 0000-00-00 |
LARTRUVO HUMAN PRESCRIPTION DRUG Details:
Item Description | LARTRUVO from Eli Lilly and Company |
LABELER NAME: | Eli Lilly and Company |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/mL) |
START MARKETING DATE: | 2016-10-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0002-7190_1742bd54-1adb-4528-9617-5a39f07dd957 |
PRODUCT NDC: | 0002-7190 |
APPLICATION NUMBER: | BLA761038 |
Other OLARATUMAB Pharmaceutical Manufacturers / Labelers: